Search Results

There are 123706 results for: content related to: Mutational analysis of the ARAF gene in human cancers

  1. Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma

    The Journal of Pathology

    Volume 217, Issue 5, April 2009, Pages: 707–715, Essa Y Baitei, Minjing Zou, Futwan Al-Mohanna, Katharine Collison, Ali S Alzahrani, Nadir R Farid, Brian Meyer and Yufei Shi

    Version of Record online : 13 NOV 2008, DOI: 10.1002/path.2496

  2. You have free access to this content
    Melanoma 2010 Congress

    Pigment Cell & Melanoma Research

    Volume 23, Issue 6, December 2010, Pages: 874–1004,

    Version of Record online : 13 OCT 2010, DOI: 10.1111/j.1755-148X.2010.00767.x

  3. You have free access to this content
    Society for Melanoma Research 2014 Congress

    Pigment Cell & Melanoma Research

    Volume 27, Issue 6, November 2014, Pages: 1169–1241,

    Version of Record online : 23 OCT 2014, DOI: 10.1111/pcmr.12317

  4. Society for Melanoma Research 2009 International Congress

    Pigment Cell & Melanoma Research

    Volume 22, Issue 6, December 2009, Pages: 860–906,

    Version of Record online : 14 OCT 2009, DOI: 10.1111/j.1755-148X.2009.00639.x

  5. Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis

    Genes, Chromosomes and Cancer

    Volume 52, Issue 1, January 2013, Pages: 99–106, Rina Kansal, Leticia Quintanilla-Martinez, Vivekananda Datta, Jean Lopategui, Gary Garshfield and Bharat N. Nathwani

    Version of Record online : 21 SEP 2012, DOI: 10.1002/gcc.22010

  6. You have free access to this content
    Oncogenic mutations in extramammary Paget's disease and their clinical relevance

    International Journal of Cancer

    Volume 132, Issue 4, 15 February 2013, Pages: 824–831, Zhihua Kang, Feng Xu, Qiao-an Zhang, Zhiyuan Wu, Xinju Zhang, Jinhua Xu, Yan Luo and Ming Guan

    Version of Record online : 7 AUG 2012, DOI: 10.1002/ijc.27738

  7. You have free access to this content
    Functional characterization of the novel BRAF complex mutation, BRAFV600delinsYM, identified in papillary thyroid carcinoma

    International Journal of Cancer

    Volume 132, Issue 3, 1 February 2013, Pages: 738–743, Michiko Matsuse, Norisato Mitsutake, Susumu Tanimura, Tomoo Ogi, Eijun Nishihara, Mitsuyoshi Hirokawa, Cesar S. Fuziwara, Vladimir A. Saenko, Keiji Suzuki, Akira Miyauchi and Shunichi Yamashita

    Version of Record online : 21 JUL 2012, DOI: 10.1002/ijc.27709

  8. Concurrent TERT promoter and BRAF V600E mutation in epithelioid glioblastoma and concomitant low-grade astrocytoma

    Neuropathology

    Nozomi Matsumura, Nozomi Nakajima, Tatsuya Yamazaki, Takuro Nagano, Kaie Kagoshima, Sumihito Nobusawa, Hayato Ikota and Hideaki Yokoo

    Version of Record online : 15 JUN 2016, DOI: 10.1111/neup.12318

  9. You have free access to this content
    The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer

    Cancer

    Volume 118, Issue 7, 1 April 2012, Pages: 1764–1773, Tae Hyuk Kim, Young Joo Park, Jung Ah Lim, Hwa Young Ahn, Eun Kyung Lee, You Jin Lee, Kyung Won Kim, Seo Kyung Hahn, Yeo Kyu Youn, Kwang Hyun Kim, Bo Youn Cho and Do Joon Park

    Version of Record online : 31 AUG 2011, DOI: 10.1002/cncr.26500

  10. You have free access to this content
    Mutations of BRAF and RAS are rare events in germ cell tumours

    International Journal of Cancer

    Volume 113, Issue 2, 10 January 2005, Pages: 329–335, Florian Sommerer, Ulrich R. Hengge, Annett Markwarth, Susanne Vomschloss, Jens-Uwe Stolzenburg, Christian Wittekind and Andrea Tannapfel

    Version of Record online : 13 SEP 2004, DOI: 10.1002/ijc.20567

  11. You have free access to this content
    Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas

    International Journal of Cancer

    Volume 108, Issue 2, 10 January 2004, Pages: 237–242, Koji Koinuma, Kazuhisa Shitoh, Yasuyuki Miyakura, Taiji Furukawa, Yoshihiro Yamashita, Jun Ota, Ruri Ohki, Young Lim Choi, Tomoaki Wada, Fumio Konishi, Hideo Nagai and Hiroyuki Mano

    Version of Record online : 27 OCT 2003, DOI: 10.1002/ijc.11523

  12. You have free access to this content
    Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights

    Cancer Cytopathology

    Volume 123, Issue 10, October 2015, Pages: 593–602, Esther Diana Rossi, Maurizio Martini, Tommaso Bizzarro, Sara Capodimonti, Tonia Cenci, Celestino Pio Lombardi, Alfredo Pontecorvi, Guido Fadda and Luigi Maria Larocca

    Version of Record online : 31 JUL 2015, DOI: 10.1002/cncy.21586

  13. Increased CYP24A1 expression is associated with BRAFV600E mutation and advanced stages in papillary thyroid carcinoma

    Clinical Endocrinology

    Volume 81, Issue 1, July 2014, Pages: 109–116, Minjing Zou, Faisal S. BinHumaid, Ali S. Alzahrani, Essa Y. Baitei, Futwan A. Al-Mohanna, Brian F. Meyer and Yufei Shi

    Version of Record online : 21 JAN 2014, DOI: 10.1111/cen.12396

  14. You have free access to this content
    Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer

    International Journal of Cancer

    Volume 119, Issue 10, 15 November 2006, Pages: 2322–2329, Shuiying Hu, Dingxie Liu, Ralph P. Tufano, Kathryn A. Carson, Eli Rosenbaum, Yoram Cohen, Elizabeth H. Holt, Katja Kiseljak-Vassiliades, Kerry J. Rhoden, Sara Tolaney, Stephen Condouris, Giovanni Tallini, William H. Westra, Christopher B. Umbricht, Martha A. Zeiger, Joseph A. Califano, Vasily Vasko and Mingzhao Xing

    Version of Record online : 20 JUL 2006, DOI: 10.1002/ijc.22110

  15. Low-concentration vemurafenib induces the proliferation and invasion of human HaCaT keratinocytes through mitogen-activated protein kinase pathway activation

    The Journal of Dermatology

    Volume 42, Issue 9, September 2015, Pages: 881–888, Mi Ryung Roh, Jung Min Kim, Sang Hee Lee, Hong Sun Jang, Kyu Hyun Park, Kee Yang Chung and Sun Young Rha

    Version of Record online : 5 JUN 2015, DOI: 10.1111/1346-8138.12950

  16. KIAA1549-BRAF Fusions and IDH Mutations Can Coexist in Diffuse Gliomas of Adults

    Brain Pathology

    Volume 22, Issue 6, November 2012, Pages: 841–847, Manuela Badiali, Vincent Gleize, Sophie Paris, Loredana Moi, Selma Elhouadani, Antonietta Arcella, Roberta Morace, Manila Antonelli, Francesca Romana Buttarelli, Dominique Figarella- Branger, Young-Ho Kim, Hiroko Ohgaki, Karima Mokhtari, Marc Sanson and Felice Giangaspero

    Version of Record online : 18 JUN 2012, DOI: 10.1111/j.1750-3639.2012.00603.x

  17. Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease

    Histopathology

    Volume 69, Issue 3, September 2016, Pages: 499–509, Michal Kamionek, Parnian Ahmadi Moghaddam, Ali Sakhdari, Alexandra E Kovach, Matthew Welch, Xiuling Meng, Karen Dresser, Keith Tomaszewicz, Ediz F Cosar, Eugene J Mark, Armando E Fraire and Lloyd Hutchinson

    Version of Record online : 29 APR 2016, DOI: 10.1111/his.12955

  18. BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel

    British Journal of Dermatology

    Volume 168, Issue 4, April 2013, Pages: 700–707, D. Gonzalez, L. Fearfield, P. Nathan, P. Tanière, A. Wallace, E. Brown, C. Harwood, J. Marsden and S. Whittaker

    Version of Record online : 25 MAR 2013, DOI: 10.1111/bjd.12248

  19. BRAF,KIT and NRAS mutations and expression of c-KIT, phosphorylated extracellular signal-regulated kinase and phosphorylated AKT in Japanese melanoma patients

    The Journal of Dermatology

    Volume 42, Issue 5, May 2015, Pages: 477–484, Satomi Oyama, Yoko Funasaka, Atsushi Watanabe, Toshihiro Takizawa, Seiji Kawana and Hidehisa Saeki

    Version of Record online : 13 MAR 2015, DOI: 10.1111/1346-8138.12822

  20. Germline mutation in BRAF codon 600 is compatible with human development: de novo p.V600G mutation identified in a patient with CFC syndrome

    Clinical Genetics

    Volume 79, Issue 5, May 2011, Pages: 468–474, KJ Champion, C Bunag, AL Estep, JR Jones, CH Bolt, RC Rogers, KA Rauen and DB Everman

    Version of Record online : 28 JUN 2010, DOI: 10.1111/j.1399-0004.2010.01495.x